Human microbiome in health and disease

Annual Review of Pathology: Mechanisms of Disease

Volumn 7, Issue , 2012, Pages 99-122

  Pflughoeft, Kathryn J ^a   Versalovic, James ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Diversity; Dysbiosis; Metagenomics; Microbiota; Pathogens; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 5;

ABDOMINAL PAIN; ACUTE GASTROENTERITIS; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC THERAPY; ANTIMICROBIAL ASSOCIATED DIARRHEA; BACTERIAL GENE; CARBOHYDRATE METABOLISM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM HISTOLYTICUM; COLITIS; CROHN DISEASE; DENTAL CARIES; DIABETES MELLITUS; DIARRHEA; ESCHERICHIA COLI O157; GENE EXPRESSION; GENE TRANSFER; GRANULICATELLA; HELICOBACTER PYLORI; HUMAN; HUMAN MICROBIOME; IRRITABLE COLON; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; OBESITY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; QUORUM SENSING; RECURRENT ABDOMINAL PAIN; RECURRENT DISEASE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SKIN DISEASE; STREPTOCOCCUS GORDONII; TOOTH PLAQUE; ULCERATIVE COLITIS; VAGINITIS; VEILLONELLA PARVULA;

ANIMALS; DISEASE; DISEASE SUSCEPTIBILITY; GENE TRANSFER, HORIZONTAL; HUMANS; METAGENOME; METAGENOMICS; MICROBIAL INTERACTIONS; SEQUENCE ANALYSIS, DNA; SYSTEMS BIOLOGY;

EID: 84856901973     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011811-132421     Document Type: Review

References (117)

1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-59 (Pubitemid 43839542)
2. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, et al. 2009. The NIH Human Microbiome Project. Genome Res. 19:2317-23
3. Blaser MJ, Falkow S. 2009. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 7:887-94
4. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. 2009. Bacterial community variation in human body habitats across space and time. Science 326:1694-97
5. Lozupone CA, Knight R. 2008. Species divergence and the measurement of microbial diversity. FEMS Microbiol. Rev. 32:557-78 (Pubitemid 351799685)
6. Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, et al. 2010. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466:334-38
7. Dethlefsen L, McFall-Ngai M, Relman DA. 2007. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811-18 (Pubitemid 47598621)
8. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, et al. 2008. A diversity profile of the human skin microbiota. Genome Res. 18:1043-50 (Pubitemid 351931155)
9. Reid G, Younes JA, Van derMei HC, Gloor GB, Knight R, Busscher HJ. 2011. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 9:27-38
10. Spor A, Koren O, Ley R. 2011. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9:279-90
11. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280
12. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5:e177
13. Eggesbo M, Moen B, Peddada S, Baird D, Rugtveit J, et al. 2011. Development of gut microbiota in infants not exposed to medical interventions. Acta Pathol. Microbiol. Immunol. Scand. 119:17-35
14. De Filippo C, Cavalieri D, Di PaolaM, Ramazzotti M, Poullet JB, et al. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107:14691-96
15. Dethlefsen L, Relman DA. 2010. Microbes and Health Sackler Colloquium: incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 108:4554-61
16. Proal AD, Albert PJ, Marshall T. 2009. Auto. disease in the era of the metagenome. Autoimmun. Rev. 8:677-81
17. Hanin A, Sava I, Bao Y, Huebner J, Hartke A, et al. 2010. Screening of in vivo activated genes in Enterococcus faecalis during insect and mouse infections and growth in urine. PLoS ONE 5:e11879
18. Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8:471-80
19. Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J. 2009. Metagenomic pyrosequencing and microbial identification. Clin. Chem. 55:856-66
20. Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, et al. 2010. Acatalog of reference genomes from the human microbiome. Science 328:994-99
21. Bassler BL, Losick R. 2006. Bacterially speaking. Cell 125:237-46
22. Andrey DO, Renzoni A, Monod A, Lew DP, Cheung AL, Kelley WL. 2010. Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA. J. Bacteriol. 192:6077-85
23. Lupp C, Ruby EG. 2005. Vibrio fischeri uses two quorum-sensing systems for the regulation of early and late colonization factors. J. Bacteriol. 187:3620-29 (Pubitemid 40705563)
24. Laughton JM, Devillard E, Heinrichs DE, Reid G, McCormick JK. 2006. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology 152:1155-67
25. Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. 2011. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. USA 108:3360-65
26. Medellin-Pena MJ, Wang H, Johnson R, Anand S, Griffiths MW. 2007. Probiotics affect virulencerelated gene expression in Escherichia coli O157:H7. Appl. Environ. Microbiol. 73:4259-67 (Pubitemid 47068166)
27. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, et al. 2009. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6:279-89
28. Lebeer S, Vanderleyden J, De Keersmaecker SC. 2008. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 72:728-64
29. Strozzi GP, Mogna L. 2008. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J. Clin. Gastroenterol. 42(Suppl. 3):179-84
30. van Reenen CA, Dicks LM. 2011. Horizontal gene transfer amongst probiotic lactic acid bacteria and other intestinal microbiota: What are the possibilities? A review. Arch. Microbiol. 193:157-68
31. Hord NG. 2008. Eukaryotic-microbiota cross talk: potential mechanisms for health benefits of prebiotics and probiotics. Annu. Rev. Nutr. 28:215-31
32. Kelly BG, Vespermann A, Bolton DJ. 2009. Horizontal gene transfer of virulence determinants in selected bacterial foodborne pathogens. Food Chem. Toxicol. 47:969-77
33. Sommer MO, Church GM, Dantas G. 2010. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 1:299-303
34. Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464:908-12
35. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-32 (Pubitemid 41612354)
36. Lazarevic V, Whiteson K, Hernandez D, Francois P, Schrenzel J. 2010. Study of inter- and intraindividual variations in the salivary microbiota. BMC Genomics 11:523
37. Zaura E, Keijser BJ, Huse SM, Crielaard W. 2009. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol. 9:259
38. Nasidze I, Li J, Quinque D, Tang K, Stoneking M. 2009. Global diversity in the human salivary microbiome. Genome Res. 19:636-43
39. JenkinsonHF, Lamont RJ. 2005. Oral microbial communities in sickness and in health. Trends Microbiol. 13:589-95 (Pubitemid 41661340)
40. Ling Z, Kong J, Jia P, Wei C, Wang Y, et al. 2010. Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing. Microb. Ecol. 60:677-90
41. Kanasi E, Dewhirst FE, ChalmersNI, Kent R Jr, Moore A, et al. 2010. Clonal analysis of the microbiota of severe early childhood caries. Caries Res. 44:485-97
42. Marsh PD. 2003. Are dental diseases examples of ecological catastrophes? Microbiology 149:279-94 (Pubitemid 36285186)
43. Colombo AV, Silva CM, Haffajee A, Colombo AP. 2006. Identification of oral bacteria associated with crevicular epithelial cells from chronic periodontitis lesions. J. Med. Microbiol. 55:609-15
44. Mans JJ, von Lackum K, Dorsey C, Willis S, Wallet SM, et al. 2009. The degree of microbiome complexity influences the epithelial response to infection. BMC Genomics 10:380
45. Handfield M, Mans JJ, Zheng G, Lopez MC, Mao S, et al. 2005. Distinct transcriptional profiles characterize oral epithelium-microbiota interactions. Cell Microbiol. 7:811-23 (Pubitemid 40740377)
46. Hooper LV, Gordon JI. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115-18 (Pubitemid 32440925)
47. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, et al. 2010. Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations. Cell 141:1241-52
48. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228-31
49. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, et al. 2011. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 94:58-65
50. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101:15718-23 (Pubitemid 39473554)
51. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174-80
52. ColladoMC, Isolauri E, Laitinen K, Salminen S. 2010. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am. J. Clin. Nutr. 92:1023-30
53. Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, et al. 2008. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol. 4:219
54. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, et al. 2011. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. USA 108(Suppl. 1):4523-30
55. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, et al. 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085
56. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, et al. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307:1955-59 (Pubitemid 40404703)
57. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. 2009. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137:588-97
58. Warren JR, Marshall BJ. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-75
59. Versalovic J. 2003. Helicobacter pylori. Pathology and diagnostic strategies. Am. J. Clin. Pathol. 119:403-12 (Pubitemid 37047864)
60. Morowitz MJ, Denef VJ, Costello EK, Thomas BC, Poroyko V, et al. 2011. Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc. Natl. Acad. Sci. USA 108:1128-33
61. Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, et al. 2006. Diarrhea etiology in a children's hospital emergency department: a prospective cohort study. Clin. Infect. Dis. 43:807-13 (Pubitemid 44435504)
62. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-47
63. Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, et al. 2007. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J. Clin. Microbiol. 45:1954-62 (Pubitemid 46933932)
64. Boyce JM, Havill NL. 2005. Nosocomial antibiotic-associated diarrhea associated with enterotoxinproducing strains of methicillin-resistant Staphylococcus aureus. Am. J. Gastroenterol. 100:1828-34 (Pubitemid 41648440)
65. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, et al. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197:435-38 (Pubitemid 351263426)
66. Aas J, Gessert CE, Bakken JS. 2003. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis. 36:580-85 (Pubitemid 36259562)
67. Yoon SS, Brandt LJ. 2010. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J. Clin. Gastroenterol. 44:562-66
68. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. 2010. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 44:354-60
69. Pillai A, Nelson R. 2008. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst. Rev. CD004611
70. Johnston BC, Supina AL, Ospina M, Vohra S. 2007. Probiotics for the prevention of pediatric antibioticassociated diarrhea. Cochrane Database Syst. Rev. CD004827
71. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, et al. 2001. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-28 (Pubitemid 32568333)
72. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603 (Pubitemid 32531408)
73. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606 (Pubitemid 32531409)
74. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-94 (Pubitemid 351173057)
75. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65
76. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104:13780-85 (Pubitemid 350003397)
77. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, et al. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844-54, e1841
78. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, et al. 2009. Towards the human intestinalmicrobiota phylogenetic core. Environ. Microbiol. 11:2574-84
79. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, et al. 2009. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15:653-60
80. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105:16731-36
81. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. 2008. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 14:147-61 (Pubitemid 351288036)
82. Li M, Wang B, ZhangM, Rantalainen M, Wang S, et al. 2008. Symbiotic gut microbesmodulate human metabolic phenotypes. Proc. Natl. Acad. Sci. USA 105:2117-22 (Pubitemid 351439474)
83. Swidsinski A, Dorffel Y, Loening-Baucke V, Theissig F, Ruckert JC, et al. 2011. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60:34-40
84. Hartman AL, Lough DM, Barupal DK, Fiehn O, Fishbein T, et al. 2009. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc. Natl. Acad. Sci. USA 106:17187-92
85. Zuckerman B, Stevenson J, Bailey V. 1987. Stomachaches and headaches in a community sample of preschool children. Pediatrics 79:677-82 (Pubitemid 17087130)
86. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. 2009. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 9:15
87. Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, et al. 2011. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 108:3047-52
88. Bienenstock J, Collins S. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders. Psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin. Exp. Immunol. 160:85-91
89. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100:373-82 (Pubitemid 40314522)
90. Tan G, Hammond DC, Joseph G. 2005. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am. J. Clin. Hypn. 47:161-78 (Pubitemid 40209311)
91. Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, et al. 2009. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9:95 91a.
92. Saulnier DM, Riehle J, Mistretta TA, Diaz D, Raza S, et al. 2011. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 14:1782-91
93. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, et al. 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541-51 (Pubitemid 40585355)
94. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, et al. 2010. Vaginal microbiome of reproductiveage women. Proc. Natl. Acad. Sci. USA 108:4650-87
95. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107:11971-75
96. Ling Z, Kong J, Liu F, Zhu H, Chen X, et al. 2010. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 11:488
97. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. 2008. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl. Environ. Microbiol. 74:4898-909
98. Bruce AW, Chadwick P, Hassan A, VanCott GF. 1973. Recurrent urethritis in women. Can. Med. Assoc. J. 108:973-76
99. Kelly MC, Mequio MJ, Pybus V. 2003. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 11:147-56 (Pubitemid 37553423)
100. Nelson DE, Van Der Pol B, Dong Q, Revanna KV, Fan B, et al. 2010. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS ONE 5:e14116
101. Grice EA, Segre JA. 2011. The skin microbiome. Nat. Rev. Microbiol. 9:244-53
102. Fierer N, Lauber CL, Zhou N, McDonald D, Costello EK, Knight R. 2010. Forensic identification using skin bacterial communities. Proc. Natl. Acad. Sci. USA 107:6477-81
103. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. 2008. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 3:e2719
104. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, et al. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190-92
105. Kong HH. 2011. Skin microbiome: genomics-based insights into the diversity and role of skinmicrobes. Trends Mol. Med. 17:320-28
106. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, Liechty KW, Segre JA. 2010. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc. Natl. Acad. Sci. USA 107:14799-804
107. FrankDN, FeazelLM, BessesenMT, Price CS, JanoffEN, Pace NR. 2010. The human nasalmicrobiota and Staphylococcus aureus carriage. PLoS ONE 5:e10598
108. Cogen AL, Nizet V, Gallo RL. 2008. Skin microbiota: a source of disease or defence? Br. J. Dermatol. 158:442-55 (Pubitemid 351239198)
109. Gao Z, Perez-Perez GI, Chen Y, Blaser MJ. 2010. Quantitation of major human cutaneous bacterial and fungal populations. J. Clin. Microbiol. 48:3575-81
110. Paulino LC, TsengCH, Blaser MJ. 2008. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast. Res. 8:460-71 (Pubitemid 351579659)
111. Sonnenburg JL, Fischbach MA. 2011. Community health care: therapeutic opportunities in the human microbiome. Sci. Transl. Med. 3:78ps12
112. Christensen HR, Frokiaer H, Pestka JJ. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:171-78 (Pubitemid 34014116)
113. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, et al. 2006. Complete genome sequence ofUSA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-39 (Pubitemid 43326291)
114. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. 2008. Humanderived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14:166-71
115. Warburton PJ, Palmer RM, Munson MA, Wade WG. 2007. Demonstration of in vivo transfer of doxycycline resistance mediated by a novel transposon. J. Antimicrob. Chemother. 60:973-80 (Pubitemid 47617742)
116. Preidis GA, Versalovic J. 2009. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015-31
117. JiaW, Li H, Zhao L, Nicholson JK. 2008. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7:123-29 (Pubitemid 351194060)